Redwood Scientific Technologies, Inc. announced it raised $3.44 Million in an amended filing from an offering of $5 Million
Redwood Scientific Technologies, Inc. announced it raised $3.44 Million in an amended filing from an offering of $5 Million
01/28/16, 6:22 PM
Location
Money raised
$3.44 million
Industry
biotechnology
Round Type
seed
Company Info
Location
418 broadway
albany, georgia, united states
Additional Info
Redwood Scientific Technologies (RSCI) is a pharmaceutical delivery company located in Upland. CA. RSCI develops, operates, and markets sublingual delivery products. We are the global leader in thin film oral delivery strips for lifestyle issues. Our leading product TBX-FREE, is an aid to help with the addiction to nicotine. All RSCI products are registered with the FDA as over the counter and are listed in the National Drug Directory. RSCI has a robust product pipeline that will be released over the next four years. Our current products that are available range from a sleep aid to men’s sexual dysfunction aids. RSCI's market strategy focuses on direct to consumers with a secondary emphasis on large wholesale distributors. In addition, RSCI is in the developing stages of a complete product line for children. The first product to be released within that line will the version of children's Ibuprofen in an easy to administer oral thin film strip. RSCI is also expecting to have its first antibiotic on the market by early 2019 in a prescription use only.